Aerosolized vascular endothelial growth factor/stromal cell-derived factor-1α (VEGFNP/SDFNP) led to a lower pulmonary arterial pressure and prevented right ventricular hypertrophy after ...

Unfortunately, clinical symptoms of PAH are unspecific and are late manifestations of the disease. [3] As in this case, dyspnea on exertion is often the leading clinical symptom; however, dyspnea ...

gmail.com Background: Vardenafil is a new phosphodiesterase-5 inhibitor that has shown some efficacy in the treatment of pulmonary arterial hypertension (PAH). Objective: To examine the long-term ...

ANPA-0073 is under clinical development by Schrodinger and currently in Phase I for Pulmonary Arterial Hypertension. According to GlobalData, Phase I drugs for Pulmonary Arterial Hypertension have an ...

All had a shunt fraction >1.5, pulmonary vascular resistance (PVR) <5 Wood Units (WU) and pulmonary arterial wedge pressure (PAWP) <15 mm Hg. Individuals with a PVR ≥2 WU at baseline (higher PVR group ...

High blood pressure in the lungs can make travel by plane, train, or car tricky. Here's what to know beforehand.

163.com Pulmonary arterial hypertension (PAH) is a severe complication of systemic lupus erythematosus (SLE), and SLE-PAH is the most common connective tissue disease (CTD)-associated PAH in Chinese ...

The anterior tibial artery is located in the lower leg, running from the popliteal fossa just behind the knee down along the tibia and fibula, the major bones of the lower leg. It is a branch of the ...

These include effects on arterial smooth muscle cells that cause intense peripheral vasoconstriction and stimulation of cardiac myocytes and fibroblasts. The latter promotes phenotypic changes in ...

With a diagnostic suspicion of secondary pulmonary arteriovenous malformation (PAVM) following the TCPC, the patient was admitted for further evaluation and treatment. On admission, she weighed 63 kg ...